Evaluation of 1p36 markers and clinical outcome in a skull base chordoma study
Open Access
- 1 February 2008
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 10 (1), 52-60
- https://doi.org/10.1215/15228517-2007-048
Abstract
Chordomas are rare embryogenetic tumors, arising from remnants of the notochord, characterized by local invasiveness and variable tendency for recurrence. No molecular markers are currently used in a clinical setting to distinguish chordomas with an indolent or an aggressive pattern. Among the genetic lesions observed in this tumor, one of the most commonly detected is 1p loss. In a previous study we observed 1p36 loss of heterozygosity (LOH) in 85% of the analyzed chordomas. We studied a group of 16 homogeneously treated skull base chordomas (SBCs), reporting 1p36 LOH in 75% of them and determining the expression pattern of eight apoptotic genes mapped at 1p36. No tumors shared a common expression profile with nucleus pulposus, which is considered the only adult normal tissue deriving from notochord. In particular, tumor necrosis factor receptor superfamily genes TNFRSF8, TNFRSF9, and TNFRSF14 were differently expressed compared with control in a higher percentage of tumors (40%-53%) than were the remaining analyzed genes, suggesting that the deregulation of these three genes might have a role in chordoma tumorigenesis. The presence/absence of LOH and the expression/nonexpression of each apoptotic gene were studied in a survival analysis. Our results suggest that the lack of 1p36 LOH or the presence of TNFRSF8 expression might be associated with a better prognosis in patients with SBCs.This publication has 45 references indexed in Scilit:
- Update on the Cytogenetics and Molecular Genetics of ChordomaHereditary Cancer in Clinical Practice, 2005
- Expression of Matrix Metalloproteinase (MMP)-1, MMP-2, MMP-9, Cathepsin B, and Urokinase Plasminogen Activator in Non-Skull Base ChordomaAmerican Journal of Clinical Pathology, 2004
- Mapping of candidate region for chordoma development to 1p36.13 by LOH analysisInternational Journal of Cancer, 2003
- The Role of DNA Methylation in Mammalian EpigeneticsScience, 2001
- Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?Neurosurgical Focus, 2001
- Conventional external radiotherapy in the management of clivus chordomas with overt residual diseaseNeurological Sciences, 2000
- The DNA methylation paradoxTrends in Genetics, 1999
- Prognostic factors in chordoma: Role of postoperative radiotherapyEuropean Journal of Cancer, 1995
- Skull base chordomas: A review of 38 patients, 1958–88British Journal of Neurosurgery, 1993
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958